Aspirin as an Antifungal-Lock Agent in Inhibition of Candidal Biofilm Formation in Surgical Catheters

References

• Canton-Bulnes ML, Garnacho-Montero J. Practical approach to the management of catheter-related bloodstream infection. Rev Esp Quimioter. 2019;32(Suppl 2):38–41.31475809
   PubMed Web of Science ®Google Scholar
• Mermel LA, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49(1):1–45.19489710
   PubMed Web of Science ®Google Scholar
• Malek AE, Raad II. Preventing catheter-related infections in cancer patients: a review of current strategies. Expert Rev Anti Infect Ther. 2020;18(6):531–538. doi:10.1080/14787210.2020.175036732237923
   PubMed Web of Science ®Google Scholar
• Wenzel RP. Nosocomial candidemia: risk factors and attributable mortality. Clin Infect Dis. 1995;20(6):1531–1534. doi:10.1093/clinids/20.6.15317548504
   PubMed Web of Science ®Google Scholar
• Douglas LJ. Candida biofilms and their role in infection. Trends Microbiol. 2003;11(1):30–36. doi:10.1016/S0966-842X(02)00002-112526852
   PubMed Web of Science ®Google Scholar
• Chaves F, Garnacho-Montero J, Del Pozo JL, et al. Diagnosis and treatment of catheter-related bloodstream infection: clinical guidelines of the Spanish Society of Infectious Diseases and Clinical Microbiology and (SEIMC) and the Spanish Society of Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC). Med Intensiva. 2018;42(1):5–36. doi:10.1016/j.medin.2017.09.01229406956
   PubMed Web of Science ®Google Scholar
• O’Grady NP, Alexander M, Dellinger EP, et al. Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR Recomm Rep. 2002;51(RR–10):1–29.
   PubMedGoogle Scholar
• Cateau E, Rodier MH, Imbert C. In vitro efficacies of caspofungin or micafungin catheter lock solutions on Candida albicans biofilm growth. J Antimicrob Chemother. 2008;62(1):153–155. doi:10.1093/jac/dkn16018407917
   PubMed Web of Science ®Google Scholar
• Walraven CJ, Lee SA. Antifungal lock therapy. Antimicrob Agents Chemother. 2013;57(1):1–8. doi:10.1128/AAC.01351-1223070153
   PubMed Web of Science ®Google Scholar
• Imbert C, Rammaert B. What could be the role of antifungal lock-solutions? From bench to bedside. Pathogens. 2018;7(1):6. doi:10.3390/pathogens7010006
   Web of Science ®Google Scholar
• Hawser SP, Douglas LJ. Resistance of Candida albicans biofilms to antifungal agents in vitro. Antimicrob Agents Chemother. 1995;39(9):2128–2131. doi:10.1128/AAC.39.9.21288540729
   PubMed Web of Science ®Google Scholar
• Chandra J, Mukherjee PK, Leidich SD, et al. Antifungal resistance of candidal biofilms formed on denture acrylic in vitro. J Dent Res. 2001;80(3):903–908. doi:10.1177/0022034501080003110111379893
   PubMed Web of Science ®Google Scholar
• Noverr MC, Toews GB, Huffnagle GB. Production of prostaglandins and leukotrienes by pathogenic fungi. Infect Immun. 2002;70(1):400–402. doi:10.1128/IAI.70.1.400-402.200211748207
   PubMed Web of Science ®Google Scholar
• Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat N Biol. 1971;231(25):232–235. doi:10.1038/newbio231232a0
   PubMedGoogle Scholar
• Alem MA, Douglas LJ. Prostaglandin production during growth of Candida albicans biofilms. J Med Microbiol. 2005;54(11):1001–1005. doi:10.1099/jmm.0.46172-016192429
   PubMed Web of Science ®Google Scholar
• Alem MA, Douglas LJ. Effects of aspirin and other nonsteroidal anti-inflammatory drugs on biofilms and planktonic cells of Candida albicans. Antimicrob Agents Chemother. 2004;48(1):41–47. doi:10.1128/AAC.48.1.41-47.200414693516
   PubMed Web of Science ®Google Scholar
• Stepanovic S, Vukovic D, Jesic M, Ranin L. Influence of acetylsalicylic acid (aspirin) on biofilm production by Candida species. J Chemother. 2004;16(2):134–138. doi:10.1179/joc.2004.16.2.13415216946
   PubMed Web of Science ®Google Scholar
• Malek A, Raad I. Catheter- and device-related infections in critically ill cancer patients. In: Nates JL, Price KJ, editors. Oncologic Critical Care. Springer International Publishing; 2020:1401–1417.
   Google Scholar
• Ko KS, Lee JY, Song JH, Peck KR. In vitro evaluation of antibiotic lock technique for the treatment of Candida albicans, C. glabrata, and C. tropicalis biofilms. J Korean Med Sci. 2010;25(12):1722–1726. doi:10.3346/jkms.2010.25.12.172221165285
   PubMed Web of Science ®Google Scholar
• Abdelmegeed E, Shaaban MI. Cyclooxygenase inhibitors reduce biofilm formation and yeast-hypha conversion of fluconazole resistant Candida albicans. J Microbiol. 2013;51(5):598–604. doi:10.1007/s12275-013-3052-624037655
   PubMed Web of Science ®Google Scholar
• Al-Bakri AG, Othman G, Bustanji Y. The assessment of the antibacterial and antifungal activities of aspirin, EDTA and aspirin-EDTA combination and their effectiveness as antibiofilm agents. J Appl Microbiol. 2009;107(1):280–286. doi:10.1111/j.1365-2672.2009.04205.x19302313
   PubMed Web of Science ®Google Scholar
• Hawser SP, Douglas LJ. Biofilm formation by Candida species on the surface of catheter materials in vitro. Infect Immun. 1994;62(3):915–921. doi:10.1128/IAI.62.3.915-921.19948112864
   PubMed Web of Science ®Google Scholar
• Ferreira JA, Carr JH, Starling CE, de Resende MA, Donlan RM. Biofilm formation and effect of caspofungin on biofilm structure of Candida species bloodstream isolates. Antimicrob Agents Chemother. 2009;53(10):4377–4384. doi:10.1128/AAC.00316-0919546368
   PubMed Web of Science ®Google Scholar
• Soustre J, Rodier MH, Imbert-Bouyer S, Daniault G, Imbert C. Caspofungin modulates in vitro adherence of Candida albicans to plastic coated with extracellular matrix proteins. J Antimicrob Chemother. 2004;53(3):522–525. doi:10.1093/jac/dkh09914749343
   PubMed Web of Science ®Google Scholar
• Deva R, Ciccoli R, Kock L, Nigam S. Involvement of aspirin-sensitive oxylipins in vulvovaginal candidiasis. FEMS Microbiol Lett. 2001;198(1):37–43. doi:10.1111/j.1574-6968.2001.tb10616.x11325551
   PubMed Web of Science ®Google Scholar